The role of M1/M2 macrophage polarization in primary Sjogren's syndrome.


Journal

Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438

Informations de publication

Date de publication:
14 May 2024
Historique:
received: 16 01 2024
accepted: 07 05 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: epublish

Résumé

The purpose of this study was to investigate the role of macrophage polarization in the pathogenesis of primary Sjogren's syndrome (pSS). Peripheral venous blood samples were collected from 30 patients with pSS and 30 healthy controls. Minor salivary gland samples were abtainted from 10 of these patients and 10 non-pSS controls whose minor salivary gland didn't fulfill the classification criteria for pSS. Enzyme-linked immuno sorbent assay was used to examine the serum concentration of M1/M2 macrophage related cytokines (TNF-a, IL-6, IL-23, IL-4, IL-10 and TGF-β). Flow cytometry was used to examine the numbers of CD86 This study observed a significant increase in pSS patients both in the numbers of M1 macrophages in peripheral blood and serum levels of M1-related pro-inflammatory cytokines (IL-6, IL-23 and TNF-α). Conversely, M2 macrophages were downregulated in the peripheral blood of pSS patients. Similarly, in the minor salivary glands of pSS patients, the expression of M1 macrophages was increased, and that of M2 macrophages was decreased. Furthermore, a significantly positive correlation was found between the proportions of M1 macrophages in PBMCs and serum levels of IgG and RF. This study reveals the presence of an significant imbalance in M1/M2 macrophages in pSS patients. The M1 polarization of macrophages may play an central role in the pathogenesis of pSS.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to investigate the role of macrophage polarization in the pathogenesis of primary Sjogren's syndrome (pSS).
METHODS METHODS
Peripheral venous blood samples were collected from 30 patients with pSS and 30 healthy controls. Minor salivary gland samples were abtainted from 10 of these patients and 10 non-pSS controls whose minor salivary gland didn't fulfill the classification criteria for pSS. Enzyme-linked immuno sorbent assay was used to examine the serum concentration of M1/M2 macrophage related cytokines (TNF-a, IL-6, IL-23, IL-4, IL-10 and TGF-β). Flow cytometry was used to examine the numbers of CD86
RESULTS RESULTS
This study observed a significant increase in pSS patients both in the numbers of M1 macrophages in peripheral blood and serum levels of M1-related pro-inflammatory cytokines (IL-6, IL-23 and TNF-α). Conversely, M2 macrophages were downregulated in the peripheral blood of pSS patients. Similarly, in the minor salivary glands of pSS patients, the expression of M1 macrophages was increased, and that of M2 macrophages was decreased. Furthermore, a significantly positive correlation was found between the proportions of M1 macrophages in PBMCs and serum levels of IgG and RF.
CONCLUSIONS CONCLUSIONS
This study reveals the presence of an significant imbalance in M1/M2 macrophages in pSS patients. The M1 polarization of macrophages may play an central role in the pathogenesis of pSS.

Identifiants

pubmed: 38745331
doi: 10.1186/s13075-024-03340-7
pii: 10.1186/s13075-024-03340-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101

Subventions

Organisme : Key research and development projects of Science and Technology Program of Zhejiang Province
ID : 2020C03044

Informations de copyright

© 2024. The Author(s).

Références

Verstappen GM, Kroese FGM, Bootsma H. T cells in primary Sjogren’s syndrome: targets for early intervention. Rheumatology (Oxford). 2021;60(7):3088–98.
doi: 10.1093/rheumatology/kez004 pubmed: 30770920
Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren’s syndrome. J Autoimmun. 2010;34(4):400–7.
doi: 10.1016/j.jaut.2009.10.004 pubmed: 19889514
Zhou D, Mc, Namara NA. Macrophages: important players in primary Sjogren’s syndrome? Expert Rev Clin Immunol. 2014;10(4):513–20.
doi: 10.1586/1744666X.2014.900441 pubmed: 24646086
Zong Y, Yang Y, Zhao J, Li L, Luo D, Hu J, et al. Characterisation of macrophage infiltration and polarisation based on integrated transcriptomic and histological analyses in primary Sjogren’s syndrome. Front Immunol. 2023;14:1292146.
doi: 10.3389/fimmu.2023.1292146 pubmed: 38022546 pmcid: 10656691
Zhou D, Chen YT, Chen F, Gallup M, Vijmasi T, Bahrami AF, et al. Critical involvement of macrophage infiltration in the development of Sjogren’s syndrome-associated dry eye. Am J Pathol. 2012;181(3):753–60.
doi: 10.1016/j.ajpath.2012.05.014 pubmed: 22770665 pmcid: 3432423
Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y, et al. CCL22-Producing Resident macrophages enhance T cell response in Sjogren’s syndrome. Front Immunol. 2018;9:2594.
doi: 10.3389/fimmu.2018.02594 pubmed: 30467506 pmcid: 6236111
Tao J, Zhao J, Qi XM, Wu YG. Complement-mediated M2/M1 macrophage polarization may be involved in crescent formation in lupus nephritis. Int Immunopharmacol. 2021; 101(Pt A):108278.
Ahamada MM, Jia Y, Wu X. Macrophage polarization and plasticity in systemic Lupus Erythematosus. Front Immunol. 2021;12:734008.
doi: 10.3389/fimmu.2021.734008 pubmed: 34987500 pmcid: 8721097
Cutolo M, Campitiello R, Gotelli E, Soldano S. The role of M1/M2 macrophage polarization in Rheumatoid Arthritis Synovitis. Front Immunol. 2022;13:867260.
doi: 10.3389/fimmu.2022.867260 pubmed: 35663975 pmcid: 9161083
Peng Y, Zhou M, Yang H, Qu R, Qiu Y, Hao J et al. Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases. Mediators Inflamm. 2023; 2023:8821610.
Li J, Yu YF, Liu CH, Wang CM. Significance of M2 macrophage in tubulointerstitial disease secondary to primary Sjogren’s disease. Ren Fail. 2018;40(1):634–9.
doi: 10.1080/0886022X.2018.1518242 pubmed: 30396309 pmcid: 6225512
Giron-Gonzalez JA, Baturone R, Soto MJ, Marquez M, Macias I, Montes de Oca M, et al. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjogren’s syndrome. Cell Immunol. 2009;259(1):56–60.
doi: 10.1016/j.cellimm.2009.05.013 pubmed: 19540455
Fogel O, Riviere E, Seror R, Nocturne G, Boudaoud S, Ly B, et al. Role of the IL-12/IL-35 balance in patients with Sjogren syndrome. J Allergy Clin Immunol. 2018;142(1):258–68. e5.
doi: 10.1016/j.jaci.2017.07.041 pubmed: 28916184
Chen C, Liang Y, Zhang Z, Zhang Z, Yang Z. Relationships between increased circulating YKL-40, IL-6 and TNF-alpha levels and phenotypes and disease activity of primary Sjogren’s syndrome. Int Immunopharmacol. 2020;88:106878.
doi: 10.1016/j.intimp.2020.106878 pubmed: 32791244
Lu X, Li N, Zhao L, Guo D, Yi H, Yang L, et al. Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype. Exp Eye Res. 2020;191:107905.
doi: 10.1016/j.exer.2019.107905 pubmed: 31891674
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9–16.
doi: 10.1136/annrheumdis-2016-210571 pubmed: 27789466
Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol. 1968;21(5):656–60.
doi: 10.1136/jcp.21.5.656 pubmed: 5697370 pmcid: 473887
Kwok SK, Cho ML, Her YM, Oh HJ, Park MK, Lee SY, et al. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren’s syndrome. Arthritis Res Ther. 2012;14(2):R64.
doi: 10.1186/ar3780 pubmed: 22417709 pmcid: 3446432
Yoshimoto K, Tanaka M, Kojima M, Setoyama Y, Kameda H, Suzuki K, et al. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjogren’s syndrome. Arthritis Res Ther. 2011;13(5):R170.
doi: 10.1186/ar3493 pubmed: 22018243 pmcid: 3308105
Aota K, Yamanoi T, Kani K, Nakashiro KI, Ishimaru N, Azuma M. Inverse correlation between the number of CXCR3(+) macrophages and the severity of inflammatory lesions in Sjogren’s syndrome salivary glands: a pilot study. J Oral Pathol Med. 2018;47(7):710–8.
doi: 10.1111/jop.12756 pubmed: 29926992
Frangogiannis N. Transforming growth factor-beta in tissue fibrosis. J Exp Med. 2020;217(3):e20190103.
doi: 10.1084/jem.20190103 pubmed: 32997468 pmcid: 7062524
Mason GI, Hamburger J, Bowman S, Matthews JB. Salivary gland expression of transforming growth factor beta isoforms in Sjogren’s syndrome and benign lymphoepithelial lesions. Mol Pathol. 2003;56(1):52–9.
doi: 10.1136/mp.56.1.52 pubmed: 12560464 pmcid: 1187290
Maslinska M, Paradowska-Gorycka A, Manczak M, Kostyra-Grabczak K, Kwiatkowska B. The level of TGF-beta in sera of patients with primary Sjogren’s syndrome. Reumatologia. 2019;57(6):309–14.
doi: 10.5114/reum.2019.91276 pubmed: 32226163 pmcid: 7091483
Baturone R, Soto MJ, Marquez M, Macias I, de Oca MM, Medina F, et al. Health-related quality of life in patients with primary Sjogren’s syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol. 2009;38(5):386–9.
doi: 10.1080/03009740902973821 pubmed: 19575332
Zhao J, Kubo S, Nakayamada S, Shimajiri S, Zhang X, Yamaoka K, et al. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjogren’s syndrome. Mod Rheumatol. 2016;26(5):716–24.
doi: 10.3109/14397595.2015.1129694 pubmed: 26706891
Luo D, Li L, Wu Y, Yang Y, Ye Y, Hu J, et al. Mitochondria-related genes and metabolic profiles of innate and adaptive immune cells in primary Sjogren’s syndrome. Front Immunol. 2023;14:1156774.
doi: 10.3389/fimmu.2023.1156774 pubmed: 37497211 pmcid: 10366690
Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–95.
doi: 10.1172/JCI59643 pubmed: 22378047 pmcid: 3287223
Lee KE, Mun S, Kim SM, Shin W, Jung W, Paek J, et al. The inflammatory signature in monocytes of Sjogren’s syndrome and systemic lupus erythematosus, revealed by the integrated Reactome and drug target analysis. Genes Genomics. 2022;44(10):1215–29.
doi: 10.1007/s13258-022-01308-y pubmed: 36040684
Muller E, Speth M, Christopoulos PF, Lunde A, Avdagic A, Oynebraten I, et al. Both type I and type II interferons can activate Antitumor M1 macrophages when combined with TLR stimulation. Front Immunol. 2018;9:2520.
doi: 10.3389/fimmu.2018.02520 pubmed: 30450098 pmcid: 6224375

Auteurs

Xiaochan Chen (X)

Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, P.R. China.

Linjiang Zhu (L)

Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, P.R. China.

Huaxiang Wu (H)

Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Hangzhou, 310009, P.R. China. wuhx8855@zju.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH